Education
About Us
Working with TipRanks
Follow Us
Corteva (CTVA)
NYSE:CTVA
CTVA Stock Chart & Stats
$72.60
-$0.33(-0.58%)
At close: 4:00 PM EST
$72.60
-$0.33(-0.58%)
Day’s Range― - ―
52-Week Range$53.40 - $77.41
Previous CloseN/A
Volume628.04K
Average Volume (3M)3.60M
Market Cap
$49.06B
Enterprise Value$47.12B
Total Cash (Recent Filing)$4.53B
Total Debt (Recent Filing)$2.58B
Price to Earnings (P/E)45.4
Beta0.60
Next Earnings
May 06, 2026EPS Estimate
1.17Next Dividend Ex-DateN/A
Dividend Yield1.04%
Share Statistics
EPS (TTM)0.22
Shares Outstanding675,732,000
10 Day Avg. Volume4,607,813
30 Day Avg. Volume3,600,669
Financial Highlights & Ratios
PEG Ratio1.80
Price to Book (P/B)1.87
Price to Sales (P/S)2.59
P/FCF Ratio15.74
Enterprise Value/Market Cap0.96
Enterprise Value/Revenue2.71
Enterprise Value/Gross Profit5.84
Enterprise Value/Ebitda15.34
Forecast
1Y Price Target
$83.83Price Target Upside15.47% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering13
EPS Forecast (FY)3.63
Revenue Forecast (FY)$18.13B
Bulls Say, Bears Say
Bulls Say
Financial FlexibilityStrong free cash flow combined with improved working capital enhances financial flexibility to support investment, dividends, or share repurchases, which can increase investor confidence.
Strategic PartnershipsOpenness to partnerships and interest in patented molecules from other firms creates avenues for strategic deals that can expand product offerings and revenue potential.
ValuationInvestor belief that the Seed business merits a higher valuation multiple could support a stronger overall stock valuation if the market re-rates the segment.
Bears Say
Corporate Separation UncertaintyPlanned separation of Seed and Crop Chemical businesses may delay market agreement on fair value and keep valuation uncertain until the split is fully executed.
Crop Chemicals OutlookThe crop protection business faces missed sales and profitability targets, rising generic competition, and potential litigation risks that weaken growth prospects.
Macro And Financing HeadwindsHigher interest costs and adverse currency movements are expected to pressure margins and reduce reported profitability, weighing on near-term earnings visibility.
Corteva News
CTVA FAQ
What was Corteva’s price range in the past 12 months?
Corteva lowest stock price was $53.40 and its highest was $77.41 in the past 12 months.
What is Corteva’s market cap?
Corteva’s market cap is $49.06B.
When is Corteva’s upcoming earnings report date?
Corteva’s upcoming earnings report date is May 06, 2026 which is in 86 days.
How were Corteva’s earnings last quarter?
Corteva released its earnings results on Feb 03, 2026. The company reported $0.22 earnings per share for the quarter, missing the consensus estimate of $0.223 by -$0.003.
Is Corteva overvalued?
According to Wall Street analysts Corteva’s price is currently Undervalued.
Does Corteva pay dividends?
Corteva pays a Quarterly dividend of $0.18 which represents an annual dividend yield of 1.04%. See more information on Corteva dividends here
What is Corteva’s EPS estimate?
Corteva’s EPS estimate is 1.17.
How many shares outstanding does Corteva have?
Corteva has 675,732,000 shares outstanding.
What happened to Corteva’s price movement after its last earnings report?
Corteva reported an EPS of $0.22 in its last earnings report, missing expectations of $0.223. Following the earnings report the stock price went up 0.107%.
Which hedge fund is a major shareholder of Corteva?
Currently, no hedge funds are holding shares in CTVA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Corteva Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$83.83 (15.47% Upside)
$83.83 (15.47% Upside)
Blogger Sentiment
Bullish
CTVA Sentiment 100%
Sector Average 66%
Sector Average 66%
Hedge Fund Trend
Decreased
By 2.8M Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▲ 2.9%
Last 30 Days ▲ 9.1%
Last 30 Days ▲ 9.1%
News Sentiment
Bullish
Bullish news 77%
Bearish news 23%
Bearish news 23%
Technicals
SMA
Positive
20 days / 200 days
Momentum
17.61%
12-Months-Change
Fundamentals
Return on Equity
4.98%
Trailing 12-Months
Asset Growth
4.95%
Trailing 12-Months
Company Description
Corteva
Corteva, Inc. operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics. This segment also provides digital solutions that assist farmer decision-making with a view to optimize product selection, and maximize yield and profitability. The Crop Protection segment offers products that protect against weeds, insects and other pests, and diseases, as well as enhances crop health above and below ground through nitrogen management and seed-applied technologies. This segment provides herbicides, insecticides, nitrogen stabilizers, and pasture and range management herbicides. It serves agricultural input industry. The company operates in the United States, Canada, Latin America, the Asia Pacific, Europe, the Middle East, and Africa. Corteva, Inc. was incorporated in 2018 and is headquartered in Indianapolis, Indiana.
CTVA Company Deck
CTVA Earnings Call
Q4 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call conveyed a broadly positive outlook driven by strong 2025 results (14% EBITDA growth, margin expansion to >22%, $2.9B FCF), successful strategic progress (Bayer settlement accelerating licensing and reducing royalty risk), and reiterated 2026 guidance with continued productivity targets. Key near-term risks include Q4 timing-related volume softness, competitive pricing pressures in Crop Protection (notably Brazil), currency headwinds in 2025 and expected tariff impacts in 2026, along with higher SG&A/R&D and potential normalization of working capital that could temper free cash flow. On balance, the company highlighted more material progress and upside catalysts than offsets, with a clear path to additional licensing revenue and margin/cash improvement.View all CTVA earnings summariesCTVA Revenue Breakdown
38.42% Corn
11.40% Soybean
3.86% Other oilseeds
2.77% Other
21.29% Herbicides
10.14% Insecticides
6.39% Fungicides
2.82% Biologicals
2.91% Other
CTVA Stock 12 Month Forecast
Average Price Target
$83.83
▲(15.47% Upside)
Technical Analysis
Ownership Overview
0.14% Insiders
28.39% Mutual Funds
0.29% Other Institutional Investors
47.01% Public Companies and Individual Investors